A NIS Registry of the Prospective Structured Care In Acute Coronary Syndrome
NCT ID: NCT01490645
Last Updated: 2014-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1006 participants
OBSERVATIONAL
2011-12-31
2014-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions
NCT00180466
Intracoronary Features in the Prognosis of Endothelial Dysfunction and MACES in Population With Acute Coronary Syndrome
NCT03583047
INOCA-NA a Local Prospective Registry
NCT06588244
French Registry of Acute Coronary Syndrome With or Without ST Elevation 2010
NCT01237418
Registry of Secondary Revascularization
NCT03349385
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
one group (all patients)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Myocardial infarction (UA, STEMI and NSTEMI) occurring in patients already hospitalized for other reasons.
* Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language, known diagnosed psychiatric illness
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Helmut Brasch, Prof. Dr.
Role: STUDY_DIRECTOR
AstraZeneca Germany
Franz Goss, Dr. med.
Role: PRINCIPAL_INVESTIGATOR
80331 Munich, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Arnstadt, , Germany
Research Site
Augsburg, , Germany
Research Site
Bad Soden, , Germany
Research Site
Berlin, , Germany
Research Site
Berlin-Helersdorf, , Germany
Research Site
Berlin-Humbold, , Germany
Research Site
Berlin-Pankow, , Germany
Research Site
Berlin-Spandau, , Germany
Research Site
Bonn, , Germany
Research Site
Buchholz, , Germany
Research Site
Chemnitz, , Germany
Research Site
Coburg, , Germany
Research Site
Cologne, , Germany
Research Site
Coswig, , Germany
Research Site
Cottbus, , Germany
Research Site
Dessau, , Germany
Research Site
Dinslaken, , Germany
Research Site
Düsseldorf, , Germany
Research Site
Flensburg, , Germany
Research Site
Frankfurt, , Germany
Research Site
Göttingen, , Germany
Research Site
Hamburg, , Germany
Research Site
Hilden, , Germany
Research Site
Höchberg, , Germany
Research Site
Höxter, , Germany
Research Site
Karlstadt am Main, , Germany
Research Site
Kassel, , Germany
Research Site
Kiel, , Germany
Research Site
Lichtenberg, , Germany
Research Site
Lippstadt, , Germany
Research Site
Loerrach, , Germany
Research Site
Lünen, , Germany
Research Site
Magdeburg, , Germany
Research Site
Merseburg, , Germany
Research Site
Neukölln, , Germany
Research Site
Nordhausen, , Germany
Research Site
Querfurt, , Germany
Research Site
Regensburg, , Germany
Research Site
Stralsund, , Germany
Research Site
Templin, , Germany
Research Site
Ulm, , Germany
Research Site
Ulm Donau, , Germany
Research Site
Wesel, , Germany
Research Site
Wilster, , Germany
Research Site
Würzburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-CDE-XXX-2011/1
Identifier Type: -
Identifier Source: secondary_id
NIS-CDE-XXX-2011/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.